Enzyme induction with rifampicin; lipoproteins and drug binding to alpha 1‐acid glycoprotein.
Open Access
- 1 August 1983
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 16 (2) , 195-197
- https://doi.org/10.1111/j.1365-2125.1983.tb04986.x
Abstract
Hepatic enzyme induction has been reported to increase lignocaine binding, alpha 1‐acid glycoprotein concentration and high density lipoprotein (HDL) cholesterol. In eight volunteers treated with rifampicin for 3 weeks there was no significant alteration in these three variables although their antipyrine clearance was significantly increased. In 10 patients with pulmonary tuberculosis treated with rifampicin (mean 5 months) the degree of serum protein binding of lignocaine, alpha 1‐acid glycoprotein and HDL‐cholesterol concentration was not different from that of matched control patients. These results suggest that differential induction of these variables may occur.Keywords
This publication has 11 references indexed in Scilit:
- Increased Toxicity and Reduced Clearance of Lidocaine by CimetidineAnnals of Internal Medicine, 1982
- Plasma high-density lipoproteins and hepatic microsomal enzyme inductionEuropean Journal of Clinical Pharmacology, 1982
- Lignocaine disposition in blood in epilepsy.British Journal of Clinical Pharmacology, 1981
- Effect of low‐dose phenobarbitone on five indirect indices of hepatic microsomal enzyme induction and plasma lipoproteins in normal subjects [letter]British Journal of Clinical Pharmacology, 1981
- Does rifampicin increase serum levels of testosterone and oestradiol by inducing sex hormone binding globulin capacity? [letter]British Journal of Clinical Pharmacology, 1981
- Differential induction of antipyrine metabolism by rifampicinEuropean Journal of Clinical Pharmacology, 1981
- Effect of Phenobarbitone on Plasma Apolipoprotein B and Plasma High-Density-Lipoprotein Cholesterol in Normal SubjectsClinical Science, 1979
- Measurement of urinary 6-?-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicinEuropean Journal of Clinical Pharmacology, 1979
- Increase of serum high-density lipoprotein in phenytoin users.BMJ, 1978
- Rapid gas-liquid chromatographic estimation of antipyrine in plasmaJournal of Pharmacy and Pharmacology, 1973